Archives of Craniofacial Surgery (대한두개안면성형외과학회지)

Korean Cleft Palate-Craniofacial Association (대한두개안면성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Early diagnosis and surgical treatment of primary cutaneous marginal zone B-cell lymphomas of the face in an Asian patient

  • Lee, Sam Yong (Department of Plastic and Reconstructive Surgery, Chonnam National University Medical School) ;
  • Kim, Woo Hyeong (Department of Plastic and Reconstructive Surgery, Chonnam National University Medical School) ;
  • Choi, Jun Ho (Department of Plastic and Reconstructive Surgery, Chonnam National University Medical School) ;
  • Kim, Kwang Seog (Department of Plastic and Reconstructive Surgery, Chonnam National University Medical School) ;
  • Hwang, Jae Ha (Department of Plastic and Reconstructive Surgery, Chonnam National University Medical School)
  • Received : 2021.09.29
  • Accepted : 2021.10.17
  • Published : 2021.10.20
Download PDF
⟨ Previous Next ⟩

Abstract

Primary cutaneous marginal zone B-cell lymphoma (PCMZL) is an uncommon type of malignant lymphoma that mainly occurs in the trunk and upper extremity, with less frequent incidence observed on the head. Herein, we report the early diagnosis and treatment of a rare case of facial PCMZL in an Asian patient. A 51-year-old man presented with masses on the forehead and nose tip, which he had incidentally discovered 2 months previously. The masses appeared as a papule on the forehead and a patch on the nose. There were no signs of infection or bleeding, and the patient reported no other symptoms. After complete surgical excision, PCMZL was diagnosed based on the permanent biopsy. The histopathological findings revealed lymphoid aggregations with multifocal granulomas. Further treatment and follow-up were conducted at the hematology and oncology department. Despite its rarity in Asian populations, cutaneous lymphoma should be included in the differential diagnosis of facial masses. Early diagnosis and treatment based on a physical examination, imaging study, and excisional biopsy are important for a favorable prognosis.

Keywords

References

  1. Vitiello P, Sica A, Ronchi A, Caccavale S, Franco R, Argenziano G. Primary cutaneous B-cell lymphomas: an update. Front Oncol 2020;10:651. https://doi.org/10.3389/fonc.2020.00651
  2. Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol 2015;90:687-706. https://doi.org/10.1590/abd1806-4841.20153638
  3. Kempf W, Kazakov DV, Buechner SA, Graf M, Zettl A, Zimmermann DR, et al. Primary cutaneous marginal zone lymphoma in children: a report of 3 cases and review of the literature. Am J Dermatopathol 2014;36:661-6. https://doi.org/10.1097/DAD.0000000000000062
  4. Jia J, Li W, Zheng Y. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of RCHOP chemotherapy and surgery: a case report and review of literature. Medicine (Baltimore) 2017;96:e6161. https://doi.org/10.1097/md.0000000000006161
  5. Agnihotri T, Adotama P, Kalowitz-Bieber A, Stokar E, Meehan SA, Latkowski JA. A case of primary cutaneous marginal zone lymphoma presenting with rosacea-like eruption. JAAD Case Rep 2020;6:902-4. https://doi.org/10.1016/j.jdcr.2020.07.018
  6. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85. https://doi.org/10.1182/blood-2004-09-3502
  7. Baik BS, Lee WS, Ji SY, Park KS, Yang WS, Kim SY. Treatment of primary cutaneous anaplastic large cell lymphoma. Arch Craniofac Surg 2019;20:207-11. https://doi.org/10.7181/acfs.2018.02201
  8. Dickinson PD, Patel A, Wootton C, Bessell EM, O'Connor S. Primary cutaneous marginal zone B cell lymphoma in monozygotic twins. BMJ Case Rep 2011;2011:bcr.11.2010.3515.
  9. Dumont M, Battistella M, Ram-Wolff C, Bagot M, de Masson A. Diagnosis and treatment of primary cutaneous B-cell lymphomas: state of the art and perspectives. Cancers (Basel) 2020;12:1497. https://doi.org/10.3390/cancers12061497
  10. Lang CCV, Ramelyte E, Dummer R. Innovative therapeutic approaches in primary cutaneous B cell lymphoma. Front Oncol 2020;10:1163. https://doi.org/10.3389/fonc.2020.01163
  11. Kim J, Jeong M, Jun D, Lee M, Shin D, Kim W, et al. Primary cutaneous CD4+ small/medium T-cell lymphoma: a case report. Arch Craniofac Surg 2021;22:199-203. https://doi.org/10.7181/acfs.2021.00199
  12. Lee CL, Lee IS, Jung SG. A case of nodal marginal zone B-cell lymphoma of the lower eyelid. Arch Craniofac Surg 2020;21:249-52. https://doi.org/10.7181/acfs.2020.00241
  13. Selva R, Violetti SA, Delfino C, Grandi V, Cicchelli S, Tomasini C, et al. A Literature revision in primary cutaneous B-cell lymphoma. Indian J Dermatol 2017;62:146-57. https://doi.org/10.4103/ijd.IJD_74_17
  14. Penate Y, Hernandez-Machin B, Perez-Mendez LI, Santiago F. Rosales B, Servitje O, et al. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma. Br J Dermatol 2012;167:174-9. https://doi.org/10.1111/j.1365-2133.2012.10902.x